MDGL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

18.4

Margin Of Safety %

Put/Call OI Ratio

0.37

EPS Next Q Diff

0.35

EPS Last/This Y

6.33

EPS This/Next Y

20.27

Price

510.03

Target Price

674.73

Analyst Recom

1.28

Performance Q

6.56

Upside

-187.8%

Beta

-1.07

Ticker: MDGL

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-04-13	MDGL	525.71	0.33	0.06	18236
2026-04-14	MDGL	525	0.33	0.57	18213
2026-04-15	MDGL	518.8	0.34	0.42	18688
2026-04-16	MDGL	524.17	0.34	0.18	18879
2026-04-17	MDGL	531.81	0.33	0.19	18891
2026-04-20	MDGL	527.82	0.24	0.38	14140
2026-04-21	MDGL	528.15	0.24	0.15	14232
2026-04-22	MDGL	528.62	0.24	0.52	14228
2026-04-23	MDGL	518.71	0.24	0.53	14228
2026-04-24	MDGL	512.9	0.24	1.98	14372
2026-04-27	MDGL	520.64	0.25	0.27	14515
2026-04-28	MDGL	516.37	0.25	0.04	14553
2026-04-29	MDGL	518.8	0.25	0.26	14642
2026-04-30	MDGL	516.92	0.25	0.04	14719
2026-05-01	MDGL	513.66	0.25	0.22	14768
2026-05-04	MDGL	518.06	0.25	0.06	14884
2026-05-05	MDGL	501.36	0.25	1.14	14911
2026-05-06	MDGL	539.15	0.32	0.72	16341
2026-05-07	MDGL	535.03	0.38	0.10	19732
2026-05-08	MDGL	510.24	0.38	1.00	20531
2026-05-11	MDGL	496.58	0.37	0.50	20840
2026-05-12	MDGL	509.2	0.37	0.06	21167
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-04-13	MDGL	525.53	-24.8	202.3	-5.78
2026-04-14	MDGL	525.74	-24.8	202.3	-5.78
2026-04-15	MDGL	518.78	-24.8	203.2	-5.78
2026-04-16	MDGL	524.31	-24.8	202.5	-5.78
2026-04-17	MDGL	531.77	-24.8	201.5	-5.78
2026-04-20	MDGL	527.88	-24.8	202.0	-5.78
2026-04-21	MDGL	527.89	-24.8	202.0	-5.78
2026-04-22	MDGL	529.15	-24.8	201.9	-5.78
2026-04-23	MDGL	519.49	-24.8	203.1	-5.78
2026-04-24	MDGL	513.00	-24.8	203.9	-5.78
2026-04-27	MDGL	520.25	-24.8	203.0	-5.78
2026-04-28	MDGL	516.75	-24.8	203.4	-5.78
2026-04-29	MDGL	518.55	-24.8	203.2	-5.78
2026-04-30	MDGL	516.53	-24.8	203.1	-5.78
2026-05-01	MDGL	513.59	-24.8	203.5	-5.78
2026-05-04	MDGL	518.58	-24.8	202.9	-5.78
2026-05-05	MDGL	502.27	-24.8	205.0	-5.78
2026-05-06	MDGL	538.95	-24.8	198.0	-5.78
2026-05-07	MDGL	535.38	25.9	200.7	-5.78
2026-05-08	MDGL	510.04	25.9	-	-5.78
2026-05-11	MDGL	497.08	30.7	-	-5.13
2026-05-12	MDGL	510.03	-17.4	-	-6.52
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-04-13	MDGL	-5.98	1.26	18.75
2026-04-14	MDGL	-5.98	1.26	18.75
2026-04-15	MDGL	-5.98	1.26	18.75
2026-04-17	MDGL	-5.98	1.26	18.75
2026-04-20	MDGL	-5.98	1.22	18.75
2026-04-21	MDGL	-5.98	1.22	18.75
2026-04-22	MDGL	-5.98	1.22	18.76
2026-04-23	MDGL	-5.95	1.22	18.76
2026-04-24	MDGL	-5.95	1.22	18.76
2026-04-27	MDGL	-5.95	1.18	19.26
2026-04-28	MDGL	-5.95	1.18	19.26
2026-04-29	MDGL	-5.95	1.18	19.26
2026-04-30	MDGL	-5.95	1.18	19.26
2026-05-01	MDGL	-5.95	1.18	19.26
2026-05-04	MDGL	-5.95	1.33	19.26
2026-05-05	MDGL	-5.95	1.33	19.26
2026-05-06	MDGL	-5.95	1.33	19.26
2026-05-07	MDGL	-5.95	1.33	19.26
2026-05-08	MDGL	-5.25	1.33	19.26
2026-05-11	MDGL	-5.22	1.26	19.15
2026-05-12	MDGL	-5.22	1.26	18.40
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.38

Avg. EPS Est. Current Quarter

-2.23

Avg. EPS Est. Next Quarter

-1.03

Insider Transactions

-5.22

Institutional Transactions

1.26

Beta

-1.07

Average Sales Estimate Current Quarter

351

Average Sales Estimate Next Quarter

394

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

17.1

Max Drawdown 5-Year %

-61.4

Target Price

674.73

P/E

Forward P/E

48.71

PEG

P/S

10.39

P/B

21.63

P/Free Cash Flow

EPS

-12.8

Average EPS Est. Cur. Y

-6.52

EPS Next Y. (Est.)

13.75

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-27.32

Relative Volume

0.68

Return on Equity vs Sector %

-83.8

Return on Equity vs Industry %

-68.3

EPS 1 7Days Diff

-0.7

EPS 1 30Days Diff

-0.74

EBIT Estimation

◆ MDGL Healthcare

$510.26

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

2/20

Pullback

21/25

Volume

6/15

Valuation

11/20

TP/AR

2/10

Options

8/10

RSI

49.1

Range 1M

21.2%

Sup Dist

4.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

24/30

Estimates

1/20

Inst/Vol

5/15

Options

8/10

EPS Yr

49.1%

EPS NY

260%

52W%

68.9%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +5.1% upside

Quality

7/30

Valuation

2/30

Growth

19/25

Stability

6/10

LT Trend

0/5

Upside

+5.1%

Quality

Madrigal Pharmaceuticals, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 915

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

MDGL

Latest News

—

Caricamento notizie per MDGL…

stock quote shares MDGL – Madrigal Pharmaceuticals Inc Stock Price stock today

news today MDGL – Madrigal Pharmaceuticals Inc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDGL – Madrigal Pharmaceuticals Inc yahoo finance google finance

stock history MDGL – Madrigal Pharmaceuticals Inc invest stock market

stock prices MDGL premarket after hours

ticker MDGL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MDGL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y